if you got those ksxo at .003 this morning WELL DONE !
im not cashed up at present so am missing these bargains. cannot believe ksx has slipped back, although at least the .02 mark looks gone for now.
today's announcement shows they are pushing the clinical discussion, although i must admit i thought they'd already sold the clinical case and marketing of the products was well underway. would appear they have had to go back a few steps and push the case a bit more.
revenue now the key and as i posted earlier one or two big sales in the US or Europe would suddenly put KSX on the radar.
would very much like to see an opportunistic bid for the company lob out of nowhere from our friends at resmed. might focus a few minds on what the value of the technology really is given the need for better diagnostioc services in the huge asthma market.
have to admit, afyter last week's apparent false start i await the re-rating impatiently. im not greedy. .105 for my ops will do. lol
KSX Price at posting:
2.6¢ Sentiment: ST Buy Disclosure: Held
